| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |